申请人:Boehringer Ingelheim GmbH
公开号:US04101671A1
公开(公告)日:1978-07-18
Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen or aliphatic or aromatic carboxylic acyl, R.sub.2 is hydrogen, chlorine or bromine, R.sub.3 is fluorine, alkyl of 1 to 4 carbon atoms, trifluoromethyl, cyano, carbamoyl, carboxyl, carbalkoxy, alkoxy, acetyl, 1-hydroxyethyl or ##STR2## where R.sub.6 and R.sub.7 are each alkyl, cycloalkyl, hydroxy-cycloalkyl or, together with each other and the nitrogen atom to which they are attached, pyrrolidino, piperidino or morpholino, and R.sub.4 and R.sub.5 are each hydrogen, alkyl of 1 to 5 carbon atoms, mono- or di-hydroxy (alkyl of 1 to 5 carbon atoms), alkenyl of 2 to 4 carbon atoms, cycloalkyl of 5 to 7 carbon atoms, mono- or di-hydroxy (cycloalkyl of 5 to 7 carbon atoms), benzyl, morpholinocarbonylmethyl or, together with each other and the nitrogen atom to which they are attached, pyrrolidino, piperidino, hexamethyleneimino, morpholino, N-methyl-piperazino or camphidino, Provided, however, that when R.sub.3 is carboxyl or carbalkoxy, R.sub.4 and R.sub.5 are other than hydrogen, alkyl, mono- or di-hydroxyalkyl, alkenyl, cycloalkyl, mono- or di-hydroxy-cycloalkyl or benzyl; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as anti-ulcerogenics.
化合物的公式为##STR1##其中R.sub.1是氢或脂肪族或芳香族羧酰基,R.sub.2是氢,氯或溴,R.sub.3是氟,1至4个碳原子的烷基,三氟甲基,氰基,氨基甲酰基,羧基,羧烷氧基,烷氧基,乙酰基,1-羟乙基或##STR2##其中R.sub.6和R.sub.7分别是烷基,环烷基,羟基环烷基或与彼此和它们连接的氮原子一起的吡咯啉基,哌啶基或吗啉基,R.sub.4和R.sub.5分别是氢,1至5个碳原子的烷基,1至5个碳原子的单或双羟基(烷基),2至4个碳原子的烯基,5至7个碳原子的环烷基,5至7个碳原子的单或双羟基(环烷基),苄基,吗啉甲酰甲基或与彼此和它们连接的氮原子一起的吡咯啉基,哌啶基,己亚甲基亚胺,吗啉,N-甲基哌嗪或松香亚胺,但是当R.sub.3是羧基或羧烷氧基时,R.sub.4和R.sub.5除了烷基,单或双羟基烷基,烯基,环烷基,单或双羟基环烷基或苄基外,不能是氢;及其非毒性、药理学上可接受的酸盐。这些化合物及其盐可用作抗溃疡剂。